Bellicum Pharmaceuticals, Inc. (BLCM): Price and Financial Metrics
Bellicum Pharmaceuticals, Inc. (BLCM)
Today's Latest Price: $2.29 USD
0.19 (9.05%)
Updated Jan 17 12:00am
Add BLCM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BLCM Stock Summary
- With a price/sales ratio of 36.33, Bellicum Pharmaceuticals Inc has a higher such ratio than 96.09% of stocks in our set.
- As for revenue growth, note that BLCM's revenue has grown 214.21% over the past 12 months; that beats the revenue growth of 96.99% of US companies in our set.
- The volatility of Bellicum Pharmaceuticals Inc's share price is greater than that of 95.23% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Bellicum Pharmaceuticals Inc are NOVN, ADXS, MEIP, DRNA, and RARE.
- Visit BLCM's SEC page to see the company's official filings. To visit the company's web site, go to www.bellicum.com.
BLCM Daily Price Range
BLCM 52-Week Price Range
BLCM Stock Price Chart More Charts
BLCM Price/Volume Stats
| Current price | $2.29 | 52-week high | $4.14 |
| Prev. close | $2.10 | 52-week low | $0.72 |
| Day low | $2.10 | Volume | 8,624,000 |
| Day high | $2.79 | Avg. volume | 2,515,242 |
| 50-day MA | $1.10 | Dividend yield | N/A |
| 200-day MA | $1.61 | Market Cap | 114.33M |
Bellicum Pharmaceuticals, Inc. (BLCM) Company Bio
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The company was founded in 2004 and is based in Houston, Texas.
Top Stories View All
Best & Worst Performing Stock Industries for January 20, 2020
Best & Worst Performing Small Cap Stocks for January 20, 2020
Best & Worst Performing Mid Cap Stocks for January 20, 2020
Best & Worst Performing Large Cap Stocks for January 20, 2020
Best & Worst Performing Mega Cap Stocks for January 20, 2020
View All Top Stories
Loading social stream, please wait...